No profile data available.
Fortrea Holdings Inc. (FTRE) is a healthcare company in the trial phase contract research industry, based in Durham, United States, with about 14,000 full-time employees.
It reported revenue of $2.72 billion for fiscal year 2025, up 1.0% from fiscal year 2024, and net income of -$986.20 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $678.20 million, down 4.5% from a year before. North America was its largest region in fiscal year 2025, with 47% of revenue. Its market capitalization was $1.98 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
Fortrea reported $2.72 billion in revenue for fiscal year 2025, up 1.0% from $2.70 billion in fiscal year 2024. In Q2 2026 revenue was $678.20 million.
North America: 47% of revenue by region in fiscal year 2025, followed by Europe (31%).
$1.98 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (trial phase contract research) include Iqvia Holdings Inc. (IQV), Medpace Holdings, Inc. (MEDP), Cannabis Bioscience International Holdings, Inc. (CBIH).